Assessment of the Role of Omentopexy in Laparoscopic Sleeve Gastrectomy: A Tertiary Center Experience

Fouad, Mina; Ibraheim, Sandy Maher Naguib; Ibraheim, Peter; Maurice, Karim K.; Saber, Arsany Talaat

doi:10.1089/lap.2021.0770

Cited by 11 publications

(12 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, diagnosis was done 1 year postoperatively. This nding is also con rmed by Fouad et al 2022 study (27); which found 1 year postoperatively that 63 out of 406 patients and 7 out of 419 patients had postoperative de novo GERD (de ned as GERD-Q score > 8) in the control group and the OP/GP group, respectively. Yapalak et al 2022 (24) found by using the gastrointestinal symptom rate scale (GSRS) survey results, that re ux symptoms in the rst week were found to be signi cantly lower in OP/GP group.…”

Section: Op/gp Vs Control Regarding Postoperativesupporting

confidence: 75%

“…This nding is supported by the Nosrati et al 2021 nonrandomized cohort study (30) which found that prolonged nausea observed at 12 months postoperatively was less in patients who had OP/GP. In addition, Fouad et al 2022 prospective cohort study (27) found by using the quality of alimentation questionnaire that patients with OP/GP had lower frequency of vomiting at 12 months postoperatively. Having said that, Afaneh et al 2015 RCT (19) found by using the Rhode Index scores; that nausea and vomiting didn't signi cantly differ between the 2 groups in the long-term.…”

Section: Prolonged Postoperative Nausea and Vomiting (Ponv)mentioning

confidence: 99%

See 1 more Smart Citation

Omentopexy/Gastropexy (OP/GP) in Sleeve Gastrectomy Appears to Decrease the Incidence of Gastric Twist, Motility Related Complications, Leaks, and Bleeding. A Meta-Analysis of 17 Comparative Studies and a Plea for Routine OP/GP

Diab

Alfieri

Deblieux

et al. 2023

Preprint

View full text Add to dashboard Cite

Laparoscopic sleeve gastrectomy (LSG) can cause gastric twist/torsion, gastroesophageal reflux disease (GERD), and prolonged postoperative nausea and vomiting (PONV). In addition, bleeding and leaks are the most feared complications in the early postoperative period. Various staple line reinforcement (SLR) techniques have been innovated to reduce the incidence of bleeding and leaks; as oversewing (OS), omentopexy/gastropexy (OP/GP), buttressing, and gluing. OP/GP isn’t only an SLR method that is used for prevention of bleeding and leaks, but also a staple line fixation method that few surgeons use to prevent gastric twist/torsion, and motility related complications as GERD and prolonged PONV. The goal of this study is to compare postoperative outcomes between LSG with OP/GP and LSG without OP/GP or any other SLR method. Key points • OP/GP decreases, leaks, bleeding, readmissions, prolonged PONV, gastric twist/torsion, and GERD. This was consistent in all studies (no heterogeneity). • OP/GP appears to decrease length of stay and prolonged antacids use at 12 months postoperatively, but this isn’t on solid ground due to significant heterogeneity observed among studies. • The only disadvantage of OP/GP is the increase in operative time.

show abstract

Section: Op/gp Vs Control Regarding Postoperativesupporting

confidence: 75%

Section: Prolonged Postoperative Nausea and Vomiting (Ponv)mentioning

confidence: 99%

Omentopexy/Gastropexy (OP/GP) in Sleeve Gastrectomy Appears to Decrease the Incidence of Gastric Twist, Motility Related Complications, Leaks, and Bleeding. A Meta-Analysis of 17 Comparative Studies and a Plea for Routine OP/GP

Diab

Alfieri

Deblieux

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

“…After that, one reference and two guidelines were removed by reading the full text. Finally, 13 studies were included in our final analysis by conducting qualitative synthesis on retained articles 9,10,15–25 . The integrated selecting procedure is shown in the flowchart (Figure 1).…”

Section: Resultsmentioning

confidence: 99%

Effect of omentopexy/gastropexy on gastrointestinal symptoms after laparoscopic sleeve gastrectomy: A meta‐analysis of randomized controlled trials and systematic review

Zhu

Yuan

et al. 2023

Asian J Endoscop Surgery

View full text Add to dashboard Cite

Introduction The increased prevalence of obesity worldwide and low incidence of postoperative complications make the laparoscopic sleeve gastrectomy (LSG) a clear public choice for obese‐related individuals. Pre‐existing studies reported contentious outcomes regarding the association with gastrointestinal symptoms after adding omentopexy (Ome) or gastropexy (Gas) to LSG. The present meta‐analysis attempted to evaluate the pros and cons of operating Ome/Gas after LSG concerning gastrointestinal symptoms. Methods The data extraction and study quality assessment were independently performed by two individuals. The PubMed, EMBASE, Scopus, and Cochrane Library databases were systematically searched up to October 1, 2022, using the keywords LSG, omentopexy, and gastropexy to identify randomized controlled trial studies. Results Of the original 157 records, 13 studies with 3515 patients were included. LSG with Ome/Gas excels the LSG group in nausea (odds ratio [OR] = 0.57; 95% CI[0.46, 0.70]; P < .00001), reflux (OR = 0.57; 95% CI [0.46, 0.70]; P < .00001), vomiting (OR = 0.41; 95% CI [0.25, 0.67]; P = .0004) on gastrointestinal symptoms and bleeding (OR = 0.36; 95% CI [0.22, 0.59]; P < .0001), leakage (OR = 0.19; 95% CI [0.09, 0.43]; P < .0001), gastric torsion (OR = 0.23; 95% CI [0.07, 0.75]; P = .01) on post‐LSG complications. Further, LSG with Ome/Gas was superior to LSG regarding the result of excess body mass index loss in 1 year after surgery (mean difference = 1.83; 95% CI [0.59, 3.07]; P = .004). However, no significant associations were shown between groups in wound infection and the resulting weight or body mass index 1 year after surgery. Of note, subgroup analysis indicated that gastroesophageal reflux disease can be alleviated by adding Ome/Gas post‐LSG in those who used small bougies from 32 to 36 Fr (OR = 0.24; 95% CI [0.17, 0.34]; P < .00001) in contrast with large bougies over 36 Fr. Conclusion Most results elucidated the impact of adding Ome/Gas after LSG in reducing the incidence of gastrointestinal symptoms. Additionally, more studies should be conducted to find the relations between other indicators in the present analysis due to the poor cases.

show abstract

“…GERD outcomes after sleeve gastrectomy (SG) are signi cantly worse than after Roux-en-Y gastric bypass (RYGB), and de novo GERD and Barrett's esophagus have been reported after SG. Technical modi cations introduced to ameliorate GERD symptoms after SG are currently being investigated (3)(4)(5)(6). SG, a preferred bariatric procedure globally, has the advantages of preserving the normal continuity of the gastrointestinal tract with no anastomoses, and fewer metabolic disruptions (6).…”

Section: Introductionmentioning

confidence: 99%

“…1 Anti-re ux medication; 2 Gastroesophageal re ux disease;3 Con cence interval;4 Number of patients with valid data in the model;5 p-value for effect of time; 6 p-value for gastropexy; 7 p-value for interaction for time and gastropexy…”

mentioning

confidence: 99%

Long-term impact of gastropexy on use of acid-reducing medication, second operations for gastroesophageal reflux and subjective reflux symptoms after sleeve gastrectomy

Flølo

Fosså

Nedkvitne

et al. 2023

Preprint

View full text Add to dashboard Cite

Background/Objectives Gastopexy (G) has been introduced as a surgical technique to reduce gastroesophageal reflux disease (GERD) in patients undergoing sleeve gastrectomy (SG). We aimed to determine whether adding G to SG improves use of acid reducing medication (ARM), second operations for GERD, epigastric pain or heartburn after surgery. Subjects/Methods Patients undergoing SG at two Norwegian hospitals were included consecutively from 2011 to 2015. Data was collected prospectively up to 7 years after surgery. GERD was defined by use of ARM on a regular basis and epigastric pain and heartburn by questions derived from the Rome II classification of functional gastrointestinal disorders. G was defined as suturing the gastrocolic ligament to the staple line. Patients undergoing SG only (NG group) were compared to those with additional G (G group) by mixed effect models. Results Of 376 included patients (75% females, mean age 42.6 years and BMI 42.9 kg/m2), 350 (93%) and 232 (62%) were available for evaluation after one and 7 years, respectively. Baseline patient characteristics in the NG (n=235) and G groups (n=141) were similar. In patients without ARM use before surgery, the use increased equally in the NG and G groups up to 7 years after SG. In patients that used ARM at baseline, the proportion decreased equally in the NG and G groups. With a combined endpoint of ARM use and/or second operation for GERD, there was no difference during follow-up between the NG and G groups. With time, the proportion of patients with epigastric pain did not differ between the groups, whereas heartburn was significantly more prominent in the G group. Conclusion In this population of patients undergoing SG, adding G was not associated with reduced use of ARM and/or second operation for uncontrolled GERD, epigastric pain, or heartburn during the first 7 postoperative years.

show abstract

Assessment of the Role of Omentopexy in Laparoscopic Sleeve Gastrectomy: A Tertiary Center Experience

Cited by 11 publications

References 27 publications

Omentopexy/Gastropexy (OP/GP) in Sleeve Gastrectomy Appears to Decrease the Incidence of Gastric Twist, Motility Related Complications, Leaks, and Bleeding. A Meta-Analysis of 17 Comparative Studies and a Plea for Routine OP/GP

Omentopexy/Gastropexy (OP/GP) in Sleeve Gastrectomy Appears to Decrease the Incidence of Gastric Twist, Motility Related Complications, Leaks, and Bleeding. A Meta-Analysis of 17 Comparative Studies and a Plea for Routine OP/GP

Effect of omentopexy/gastropexy on gastrointestinal symptoms after laparoscopic sleeve gastrectomy: A meta‐analysis of randomized controlled trials and systematic review

Long-term impact of gastropexy on use of acid-reducing medication, second operations for gastroesophageal reflux and subjective reflux symptoms after sleeve gastrectomy

Contact Info

Product

Resources

About